Rare lephants
Screener

Amgen Inc.

AMGN ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
3 Sep 4, 2026 PRIMARY DOCUMENT
4 Aug 13, 2026 PRIMARY DOCUMENT
144 Aug 13, 2026
4 Aug 12, 2026 PRIMARY DOCUMENT
144 Aug 11, 2026
4 Aug 10, 2026 PRIMARY DOCUMENT
4 Aug 10, 2026 PRIMARY DOCUMENT
4 Aug 10, 2026 PRIMARY DOCUMENT
4 Aug 7, 2026 PRIMARY DOCUMENT
4 Aug 7, 2026 PRIMARY DOCUMENT
144 Aug 6, 2026
144/A Aug 6, 2026
144 Aug 6, 2026
10-Q Aug 5, 2026 10-Q
8-K Aug 4, 2026 8-K
8-K Jul 31, 2026 8-K
11-K Jun 11, 2026 11-K
11-K Jun 11, 2026 11-K
4 May 21, 2026 PRIMARY DOCUMENT
4 May 21, 2026 PRIMARY DOCUMENT
4 May 21, 2026 PRIMARY DOCUMENT
4 May 21, 2026 PRIMARY DOCUMENT
4 May 21, 2026 PRIMARY DOCUMENT
4 May 21, 2026 PRIMARY DOCUMENT
4 May 21, 2026 PRIMARY DOCUMENT
← Newer Page 1 of 124 · 3093 filings Older →